Virtual Assistant for Exercise Adherence in Older ADULTS

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age59+
SponsorUniversity of Valencia

About this trial

This study will evaluate the effectiveness of a virtual assistant-guided exercise program to improve adherence in older adults. In a nonrandomized controlled clinical trial, the experimental group will complete a 12-week, home-based program (60-minute sessions, 3 times per week) supported by a virtual assistant (BOT). The control group will comprise community-dwelling older adults already engaged in the municipal program Enguera se saludable, which delivers an in-person exercise program of comparable frequency and duration. The primary outcome is exercise adherence, defined as the proportion of prescribed sessions completed. Secondary outcomes include muscle strength, balance, functional capacity, health-related quality of life, and the user experience and usability of the virtual assistant.

Eligibility criteria

Qualifiers

Adults aged 60 years or older.

Community-dwelling individuals capable of participating in an exercise program.

Ability to complete 60-minute exercise sessions, three times per week during the 12-week intervention.

Experimental group (BOT Group): Participants willing to use a smartphone/tablet and interact with the virtual assistant.

Disqualifiers

Medical contraindications to physical exercise, as determined by clinical judgment (e.g., uncontrolled cardiovascular, respiratory, or metabolic conditions).

Severe cognitive impairment or neurological conditions that limit the ability to follow instructions or safely perform the exercise program.

Severe mobility limitations preventing participation in structured exercise (e.g., inability to walk independently with or without aid).

Acute musculoskeletal injuries or recent surgeries that contraindicate exercise participation.

Trial design

Treatments tested in this trial

  • Exercise program

Treatment groups

70 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Valencia

Lead sponsor

Generalitat Valenciana

Collaborator